Table 1.
Patient Characteristics.
| Characteristic | Intervention group (N = 30) |
Control group (N = 33) |
P value |
|---|---|---|---|
| Age (mean) a | 72.5 (9.2) | 67.8 (4.8) | .01 |
| Gender | .12 | ||
| Male | 17 (56.7%) | 25 (75.8%) | |
| Female | 13 (43.3%) | 8 (24.2%) | |
| Comorbidity | |||
| Cardiovascular disease | 13 (43.3%) | 22 (66.7%) | |
| Neurological disorders | 3 (10%) | 4 (12.1%) | |
| Gastrointestinal disorders | 12 (40%) | 7 (21.2%) | |
| Respiratory diseases | 14 (46.7%) | 10 (30.3%) | |
| Musculoskeletal disorders | 2 (6.7%) | 1 (3.0%) | |
| Endocrine diseases | 9 (30%) | 8 (24.2%) | |
| Renal impairment | 9 (30%) | 11 (33.3%) | |
| Urogenital diseases | 2 (6.7%) | 6 (18.2%) | |
| Liver impairment | 2 (6.7%) | 0 (0%) | |
| Number of comorbid per patient | |||
| 1 | 5 (16.7%) | 8 (24.2%) | .76 |
| 2 | 16 (53.3%) | 16 (48.5%) | |
| ≥3 | 9 (30%) | 9 (27.3%) | |
| Polypharmacy (number of medication) | |||
| 5 | 18 (60%) | 22 (66.7%) | .85 |
| 6 | 7 (23.3%) | 6 (18.2%) | |
| 7 | 5 (16.7%) | 5 (15.2%) | |
a
Age was reported in mean (SD).